Drug pricing is influenced by numerous factors, but technology has the potential to strike the critical balance between ...

Pharmacy benefit managers (PBMs) “invent all these special categories,” Cuban told Fortune’s Andrew Nusca. “They’re just ...

Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

Plus Oceans Healthcare adds five states with acquisition and UTA professor leads $1.8 million study.

International price referencing for certain drugs could be revisited during the second Trump administration. But it's ...

Seniors on Medicare Part D will never pay more than $2,000 out-of-pocket for prescription drugs annually, thanks to a ...

A key cost-saving provision of the Inflation Reduction Act (IRA) goes into effect in the new year, limiting annual out-of-pocket spending on prescription drugs to $2,000 for Medicare beneficiaries.

Before the law, there was no cap on what Medicare enrollees might have to spend on medications covered by their Part D drug ...

Billionaire entrepreneur Mark Cuban has been vocal about reshaping the U.S. health care system for years. During recent ...

As criticism of pharmacy benefit managers heats up, fear of lawsuits is driving some big employers to drop the “Big Three” ...

Ozempic's meteoric rise has reshaped the landscape of healthcare, retail, and consumer behavior. Its initial popularity as a weight loss ...